Tools

LEADER 01750ctm 2200373Ia 4500

005 20141212015424.0;

008 010604s2000 xx a b 000 0 eng d;

035 a| (Sirsi) H1016561;

035 a| (OCoLC)47057696;

040 a| NEHc| NEHd| UtOrBLW;

049 a| NEHH;

100 1 a| Weinstein-Oppenheimer, Caroline Ruth.?| UNAUTHORIZED;

245 10 a| Roles of the RAS-RAF-MEK-ERK signaling pathway in the development of resistance to the chemotherapeutic drug doxorubicin in the MCG-7 breast cancer cell line /c| by Caroline Ruth Weinstein-Oppenheimer.;

260 c| 2000.;

300 a| ixx, 271 leaves :b| illustrations (some color) ;c| 29 cm.;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

490 1 a| ECU Brody School of Medicine thesis;

500 a| "A Dissertation Presented to the Faculty of the Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in Microbiology and Immunology.";

502 b| Ph.D.c| East Carolina Universityd| 2000.;

504 a| Includes bibliographical references (leaves 218-271).;

650 2 a| Breast Neoplasmsx| drug therapy.=| ^A923983;

650 2 a| Doxorubicinx| pharmacology.=| ^A935184;

650 2 a| Doxorubicinx| toxicity.=| ^A935185;

650 2 a| Antieoplastic Agentsx| pharmacology.?| UNAUTHORIZED;

830 0 a| ECU Brody School of Medicine thesis.=| ^A964744;

994 a| E0b| NEH;

919 a| BOOK;

959 a| 1016561;

096 a| WP 870 W424r 2000;

596 a| 4;

998 a| 1558681;

999 a| WP 870 W424R 2000w| NLMc| 1i| 31740007268042d| 3/2/2011e| 4/8/2005f| 3/2/2011g| 2l| HSLBKm| HSLn| 7r| Ys| Yt| HBKu| 6/11/2001x| BOOKz| HSTACKSo| .STAFF. 0;

Roles of the RAS-RAF-MEK-ERK signaling pathway in the development of resistance to the chemotherapeutic drug doxorubicin in the MCG-7 breast cancer cell line / by Caroline Ruth Weinstein-Oppenheimer.

Author/creator	Weinstein-Oppenheimer, Caroline Ruth
Format	Archival & Manuscript Material
Publication Info	2000.
Description	ixx, 271 leaves : illustrations (some color) ; 29 cm.
Subjects	Breast Neoplasms--drug therapy. Doxorubicin--pharmacology. Doxorubicin--toxicity. Antieoplastic Agents--pharmacology.

Series	ECU Brody School of Medicine thesis ECU Brody School of Medicine thesis. ^A964744
General note	"A Dissertation Presented to the Faculty of the Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in Microbiology and Immunology."
Dissertation note	Ph.D. East Carolina University 2000.
Bibliography note	Includes bibliographical references (leaves 218-271).

Roles of the RAS-RAF-MEK-ERK signaling pathway in the development of resistance to the chemotherapeutic drug doxorubicin in the MCG-7 breast cancer cell line / by Caroline Ruth Weinstein-Oppenheimer.

Click here for more information about this title